AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.800
-0.080 (-2.78%)
At close: Dec 5, 2025, 4:00 PM EST
2.779
-0.021 (-0.75%)
After-hours: Dec 5, 2025, 7:51 PM EST
AC Immune Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for AC Immune stock ranges from a low of $8.00 to a high of $12. The average analyst price target of $10 forecasts a 257.14% increase in the stock price over the next year.
Price Target: $10.00 (+257.14%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 4, 2025.
Analyst Ratings
The average analyst rating for AC Immune stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +185.71% | Nov 4, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +185.71% | Sep 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $16 → $12 | Strong Buy | Maintains | $16 → $12 | +328.57% | May 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +471.43% | Apr 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +471.43% | Mar 14, 2025 |
Financial Forecast
Revenue This Year
4.41M
from 27.31M
Decreased by -83.87%
Revenue Next Year
36.96M
from 4.41M
Increased by 738.95%
EPS This Year
-0.71
from -0.51
EPS Next Year
-0.62
from -0.71
Financial currency is CHF. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 6.3M | 94.5M | ||||
| Avg | 4.4M | 37.0M | ||||
| Low | 3.1M | 4.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -76.9% | 2,044.8% | ||||
| Avg | -83.9% | 738.9% | ||||
| Low | -88.5% | 11.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.74 | -0.53 | ||||
| Avg | -0.71 | -0.62 | ||||
| Low | -0.69 | -0.70 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.